Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
The New England Journal of Medicine
|
July 10, 2026
Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression
Per-Ola Carlsson, Xiaomeng Hu, Hanne Scholz, et al.
Annals of Surgery
|
January 31, 2013
Liver transplantation for nonresectable liver metastases from colorectal cancer
Morten Hagness, Aksel Foss, Pål-Dag Line, et al.
International Journal of Molecular Sciences
|
June 12, 2026
Peripartum-Associated Heart Failure Develops Independently of RHOT Proteins
Natali Froese, Eluiesa Sina, Paolo Galuppo, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
December 24, 2009
[Liver transplantation in Norway through 25 years]
Tim Scholz, Tom H Karlsen, Truls Sanengen, et al.
Circulation Research
|
March 16, 2026
RHOT Proteins Link Mitochondrial Motility to Cardiomyocyte Sarcomere Maturation
Natali Froese, Ivanna Shymotiuk, Alexander Froese, et al.
Annals of Surgery
|
September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
Andreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
BMC Cancer
|
May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
Andreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Transplantation
|
November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
The New England Journal of Medicine
|
July 10, 2026
Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression
Per-Ola Carlsson, Xiaomeng Hu, Hanne Scholz, et al.
Annals of Surgery
|
January 31, 2013
Liver transplantation for nonresectable liver metastases from colorectal cancer
Morten Hagness, Aksel Foss, Pål-Dag Line, et al.
International Journal of Molecular Sciences
|
June 12, 2026
Peripartum-Associated Heart Failure Develops Independently of RHOT Proteins
Natali Froese, Eluiesa Sina, Paolo Galuppo, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
December 24, 2009
[Liver transplantation in Norway through 25 years]
Tim Scholz, Tom H Karlsen, Truls Sanengen, et al.
Circulation Research
|
March 16, 2026
RHOT Proteins Link Mitochondrial Motility to Cardiomyocyte Sarcomere Maturation
Natali Froese, Ivanna Shymotiuk, Alexander Froese, et al.
Annals of Surgery
|
September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
Andreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
BMC Cancer
|
May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
Andreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Transplantation
|
November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Page
of 4